missing translation for 'onlineSavingsMsg'
Learn More

CD279 (PD-1) Mouse anti-Human , PE-CF594, Clone: MIH4, BD Biosciences™

Mouse Monoclonal Antibody

Brand:  BD Biosciences 566846

1775.13 SEK valid until 2025-12-31
Use promo code "25339" to get your promotional price.


 View more versions of this product

Product Code. 17217654

  • 1780.00 SEK / 25 tests

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD279 (PD-1) Monoclonal antibody specifically detects CD279 (PD-1) in Human samples. It is validated for Flow Cytometry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD279 (PD-1)
Monoclonal
PE-CF594
PD1; hPD-1; hPD-l; PDCD1; PDC1; Programmed cell death 1; SLEB2
Human PD-1 Transfected Cell Line
RUO
Human
IgG1 κ
Flow Cytometry
MIH4
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Mouse
25 Tests
Primary
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon™ PE-CF594 under optimum conditions, and unconjugated antibody and free PE-CF594 were removed.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

One moment while we fetch your results.
Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title
CD279 (PD-1) Mouse anti-Human , PE-CF594, Clone: MIH4, BD Biosciences™ > 25 Tests; PE-CF594

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.